FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...

“When she would fall in public, people just assumed she was drunk,” said Glenn. “One time she fell backwards on the steps and ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

John Maskill, 89, decided to walk the Cinder Track after losing his wife to Progressive Supranuclear Palsy (PSP) in March.

So, let’s talk about faith. I’m no rabbi or scholar, and I’m not trying to write a religious work. But putting my thoughts ...

In The Salt Path, Raynor Winn writes that she and her husband lost their home after investing a “substantial sum” into a ...

Commercial real estate player and former Kislak President Jeffrey Wiener died July 9 after a long battle with progressive ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are both closely related sporadic parkinsonian disorders with tau pathology that share many clinical features, such as ...

Epidemiology & Pathogenesis Progressive supranuclear palsy is the most frequent parkinsonian disorder after PD. Its prevalence increases with age. [62] The average annual incidence rate for PSP ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

SUDBURY — Roland Joseph Desforges, age 85, passed away in his sleep due to complications from progressive supranuclear palsy, ...